| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/28/2006 | US20060218678 Interspecific hybrid of Lobelia and method of producing the same |
| 09/28/2006 | US20060218677 Novel gene osisap1 of rice confers tolerance to stresses and a method thereof |
| 09/28/2006 | US20060218676 Compositions and method for modulation of plant cell division |
| 09/28/2006 | US20060218675 Expression vectors for modifying oil and size phenotypes; genetic mapping variation in crop plants |
| 09/28/2006 | US20060218673 Gene silencing |
| 09/28/2006 | US20060218672 Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant |
| 09/28/2006 | US20060218671 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 09/28/2006 | US20060218670 Compositions and methods for production of sialylated glyoproteins in plants |
| 09/28/2006 | US20060218669 Sialylation of glycoproteins in plants |
| 09/28/2006 | US20060218668 -4Desaturases from euglena gracilis, expressing plants, and oils containing pufa |
| 09/28/2006 | US20060218667 Plant-produced recombinant aprotinin and aprotinin variants |
| 09/28/2006 | US20060218666 Nucleotide sequences encoding anthonomous toxic polypeptides from bacillus thuringiensis |
| 09/28/2006 | US20060218665 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/28/2006 | US20060218663 Using vector transformation to generate glyphosate resistant crops |
| 09/28/2006 | US20060218662 Introducing into a plant cell an expression cassette comprising a promoter operably linked to a heterologous nucleotide; transcription, gene expression; regenerating a transformed plant from plant cell; transgenic seeds; herbicide or pest resistance |
| 09/28/2006 | US20060218661 Novel sesquiterpene synthase gene and protein |
| 09/28/2006 | US20060218659 L450 polypeptide and nucleic acid encoding it; transgenic plant |
| 09/28/2006 | US20060218658 transforming a population of plant cells which comprises at least one marker protein having a direct or indirect toxic effect; genetic engineering using DNA construct capable of reducing the expression, amount, activity and/or function of the marker protein |
| 09/28/2006 | US20060218657 isolating primordial germ cells from avian embryonic gonad; and culturing in vitro for 10 days on a gonadal stroma feeder cell layer until positive for stage specific embryonic antigen-1; injecting into dorsal aorta of recipient chicken embryo without prior treatment; incubating and hatching egg |
| 09/28/2006 | US20060218655 Used for identifying a drug capable of treating a B cell lymphoma, capable of depleting or killing cells expressing human CD20, or capable of inducing an Fc-mediated effector cell response; testing the safety or efficacy of anti-human CD20 therapy |
| 09/28/2006 | US20060218653 determining that a single nucleotide point mutation in the fourth exon of the nucleic acid sequence encoding dog CLN5 results in the production of a variant soluble lysosomal glycoprotein, specifically CLN5, which exhibits aberrant functional activity |
| 09/28/2006 | US20060217536 Monoclonal antibody that has an extremely high binding ability to human ZAQL-1 and can neutralize or inhibit its activity, useful for diagnosing, preventing and treating endometrial cancer, endometriosis or ovulation disorders. |
| 09/28/2006 | US20060217535 Hemipteran muscarinic receptor |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060216822 Method for preparation of neo-cartilage constructs |
| 09/28/2006 | US20060216821 Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof |
| 09/28/2006 | US20060216820 Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells |
| 09/28/2006 | US20060216809 cGMP-binding, cGMP-specific phosphodiesterase materials and methods |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216785 Genetic engineering; fusion protein; comprising a recombinant vector containing a nucleic acid sequence encoding a ubiquitin like molecule (UBL) molecule selected from the group of SUMO, RUB, HUB, URM1, and ISG15 operably linked to a promoter suitable for expression in the desired host cell |
| 09/28/2006 | US20060216772 Interfacial biomaterials for binding metal substrates |
| 09/28/2006 | US20060216770 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216750 New lipid binding protein 1 |
| 09/28/2006 | US20060216749 Chimeric gaba receptor |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216699 Peptides for the detection of HIV-1 group O |
| 09/28/2006 | US20060216316 Natural Killer T (NKT) cells; modulating immune responses, such as anti-cancer responses, and enhancing memory responses |
| 09/28/2006 | US20060216314 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p7 |
| 09/28/2006 | US20060216311 Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA |
| 09/28/2006 | US20060216300 Recombinant antibodies and compositions and methods for making and using the same |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216279 Myostatin inhibiting fusion polypeptides and therapeutic methods thereof |
| 09/28/2006 | US20060216278 Entrapped stem cells and uses thereof |
| 09/28/2006 | US20060216277 Insulin-producing bone marrow derived cells and methods of generating and using same |
| 09/28/2006 | US20060216276 Use of materials for treatment of central nervous system lesions |
| 09/28/2006 | US20060216271 Synergistic combination of two adenoviral vectors that are replication incompetent cotranscomplements of each other and one is recombinant 1014; enhances both gene delivery and gene expression of genetic sequences contained within the vector. |
| 09/28/2006 | US20060216270 DNA 19355 polypeptide, a tumor necrosis factor homolog |
| 09/28/2006 | US20060216233 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/28/2006 | DE102005014623A1 Chirurgisches System zum Präparieren eines Implantats und Verfahren zum Präparieren eines Implantats A surgical system for preparing an implant and method for preparing an implant |
| 09/28/2006 | CA2800359A1 Chemically inducible expression of biosynthetic pathways |
| 09/28/2006 | CA2604507A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/28/2006 | CA2602925A1 Methods for treating tumors and cancerous tissues |
| 09/28/2006 | CA2602479A1 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 09/28/2006 | CA2602375A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | CA2602329A1 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
| 09/28/2006 | CA2602136A1 Improved proliferative capacity using cell-cell fusion generated hybrids |
| 09/28/2006 | CA2602035A1 Framework-shuffling of antibodies |
| 09/28/2006 | CA2601858A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | CA2601605A1 Methods for selecting drought resistant plants |
| 09/28/2006 | CA2601595A1 Skin substitutes with improved purity |
| 09/28/2006 | CA2601267A1 Novel anti-plgf antibody |
| 09/28/2006 | CA2541078A1 Interspecific hybrid of lobelia and method of producing the same |
| 09/27/2006 | EP1705255A2 Diagnostic method and kit for determining Kell blood group genotype |
| 09/27/2006 | EP1705251A1 PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF a1,6-FUCOSYLTRANSFERASE |
| 09/27/2006 | EP1705247A1 Dna participating in hydroxylation of macrolide compound |
| 09/27/2006 | EP1705245A1 Neural stem cells |
| 09/27/2006 | EP1705244A2 Cryopreserved hepatocytes and process for cryopreservation |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705185A2 Reagent for the diagnosis of rheumatoid arthritis |
| 09/27/2006 | EP1705184A1 Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors |
| 09/27/2006 | EP1704778A1 FO66 transgenic mice that express pathogenic mutants of the sca2 gene |
| 09/27/2006 | EP1704227A1 Immortalized hepatocytes |
| 09/27/2006 | EP1537136A4 Promoters for regulation of gene expression in plant roots |
| 09/27/2006 | EP1421172B1 Artificial synapse chip interface for electronic prosthetic retina |
| 09/27/2006 | EP1409649A4 Two chamber cell culture vessel |
| 09/27/2006 | EP1307560B1 Schizophrenia related gene and protein |
| 09/27/2006 | EP1159428B1 Method for improving the agronomic and nutritional value of plants |
| 09/27/2006 | EP1012303B1 Factor x deletion mutants and analogues thereof |
| 09/27/2006 | CN2820873Y Multiple hanging basket dewatering machine |
| 09/27/2006 | CN1839202A Process for producing cytotoxic lymphocytes |
| 09/27/2006 | CN1839198A Device and method for uniformly inoculating cell in substrate having three-dimensional surface |
| 09/27/2006 | CN1839144A Methods for humanizing rabbit monoclonal antibodies |
| 09/27/2006 | CN1838962A Injection of bone marrow-derived cells and medium for angiogenesis |
| 09/27/2006 | CN1838885A Method for treatment of sores and lesions of the skin |
| 09/27/2006 | CN1837362A SiRNA for inhibiting expression of SARS coronavirus N protein and encoding gene thereof |
| 09/27/2006 | CN1837358A Method for expanding hemopoietic stem cell under three-dimensional condition |
| 09/27/2006 | CN1837238A Monoclonal antibody against MBL and its use |
| 09/27/2006 | CN1836496A Method for obtaining chilli embryoid by microspore induction |
| 09/27/2006 | CN1836491A Method for promoting exercise survival rate of Prunus maritime cell engineered seedling |
| 09/27/2006 | CN1276975C Recombinant protein containing C-terminal fragment of plasmodium MSP-1 |
| 09/26/2006 | US7112731 transgenic corn plants and seeds, having drought tolerance, herbicide, insect and disease resistance |
| 09/26/2006 | US7112730 Inbred corn line W16090 |
| 09/26/2006 | US7112729 Hybrid maize 38W21 |
| 09/26/2006 | US7112728 Transgenic seeds for use in generation and propagation of disease, heat, freeze, insect and herbicide resistant plants; tissue engineering |
| 09/26/2006 | US7112727 Hybrid plant seed expressing peotec seeds allflesh (PSAF) allele and capable of propagating tomatoes having solid cavity areas and lacking gel or liquid present in cavities of normal tomato fruits; improving firmness, color and flavor of tomato |
| 09/26/2006 | US7112726 Cotton cultivar DP 408 BGII |
| 09/26/2006 | US7112725 transgenic cotton seeds and plants comprising regulatory sequences for modulating the expression of operably linked genes in plants |